Analysis of:
Lilly Introduces World's First Digital Insulin Pen With Memory (www.medicalnewstoday.com)
The Lilly Pen is high on technology, low on what patients need.
Analysis of:
Together Diabetes And Depression Increase Risk To Heart Patients (www.medicalnewstoday.com)
The mind cannot only heal, it can cause infirmity. Heal the mind, the body will follow.
Analysis of:
Steroid-Free Astelin(R) Nasal Spray (R) Demonstrated Seasonal Allergy Symptom Improvement Within 15 Minutes in Clinical Study (www.drugnewswire.com)
Astelin (Azelastine) nasal spray (Medpointe) proved to be effective within 15 minutes in relieving the symptoms of seasonal allergic rhinitis.Nasonex (Mometasone furoate) nasal spray (Schering) was not any more effective than placebo after 8 hoursDemonstrating the effectiveness of Astelin nasal spray...
Analysis of:
New data show fluticasone furoate nasal spray effectively treated nasal symptoms of allergic rhinitis (www.webwire.com)
This article summarizes phase III clinical data studying fluticasone furoate nasal spray. Fluticasone furoate nasal spray was more effective than placebo in controlling the nasal symptoms of perennial allergic rhinitis. Fluticasone furoate nasal spray was also more effective than placebo in controlling...
Analysis of:
Salix Pharmaceuticals Acquires PEPCID® Oral Suspension (salix.com)
Merck sells rights of Pepcid Oral Suspension to Salix.Salix markets a group of gastrointestional pharmaceuticals, adding Pepcid oral suspension to its portfolio.
Analysis of:
Live Attenuated versus Inactivated Influenza Vaccine in Infants and Young Children (content.nejm.org)
Data confirms the safety and effectiveness of Live Attenuated influenza vaccine for children age 12 to 59 months of age. 54 percent fewer cases of culture confirmed influenza occurred in a group receiving the live attenuated vaccine.Higher rates of hospitalization occurred in the 6 to 11 month...
Analysis of:
FDA OKs First Nonprescription Diet Pill (www.washingtonpost.com)
Orlistat is soon to be OTC. The cost will be 1 to 2 dollars a day.
Analysis of:
Use of Generic Drugs Is Rising, Especially Among the Elderly (online.wsj.com)
Patients are paying much more attention to medication costs.
Analysis of:
Cause of Death: Sloppy Doctors (www.time.com)
This article focuses on medical errors and physician handwriting. The article probably makes interesting reading for the general public, but I think it misses the big picture.
January 29, 2007Pfizer's Future
Analysis of:
Pfizer, Hurt by Rival Drugs, Will Lay Off 7,800 (www.nytimes.com)
Pfizer recognizes that changes are needed to prevent the continued slide in earnings and stock price. The elimination of torcetrapib, Pfizer's HDL raiser, from the pipeline, placed urgency to this issue. Look for more changes from Pfizer.